Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (836)
All Articles published online
|
Sep 21, 2009 (publication date) through Apr 20, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Yilmaz Y, Kedrah AE, Ozdogan O. Cytokeratin-18 fragments and biomarkers of the metabolic syndrome in nonalcoholic steatohepatitis. World J Gastroenterol 2009; 15(35): 4387-4391 [PMID: 19764089 DOI: 10.3748/wjg.15.4387] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v15/i35/4387.htm |
| Number | Citing Articles |
| 1 |
Hye Ran Yang. Noninvasive diagnosis of pediatric nonalcoholic fatty liver disease. Korean Journal of Pediatrics 2013; 56(2): 45 doi: 10.3345/kjp.2013.56.2.45
|
| 2 |
Romina Lomonaco, Janet Chen, Kenneth Cusi. An endocrine perspective of nonalcoholic fatty liver disease (NAFLD). Therapeutic Advances in Endocrinology and Metabolism 2011; 2(5): 211 doi: 10.1177/2042018811419157
|
| 3 |
Yusuf Yilmaz, Fatih Eren. Identification of a support vector machine-based biomarker panel with high sensitivity and specificity for nonalcoholic steatohepatitis. Clinica Chimica Acta 2012; 414: 154 doi: 10.1016/j.cca.2012.08.005
|
| 4 |
Romina Lomonaco, Nishanth E. Sunny, Fernando Bril, Kenneth Cusi. Nonalcoholic Fatty Liver Disease: Current Issues and Novel Treatment Approaches. Drugs 2013; 73(1): 1 doi: 10.1007/s40265-012-0004-0
|
| 5 |
Julien Calderaro, Elie Serge Zafrani. Stéatopathie hépatique non alcoolique. Annales de Pathologie 2010; 30(6): 413 doi: 10.1016/j.annpat.2010.10.002
|
| 6 |
Yusuf Yilmaz, Ramazan Kurt, Fatih Eren. Multimarker Strategies for Detecting NASH and NASH-Related Fibrosis: Promises and Caveats. Obesity Surgery 2011; 21(8): 1316 doi: 10.1007/s11695-011-0464-4
|
| 7 |
Raj Vuppalanchi, Robert J. Gould, Laura A. Wilson, Aynur Unalp-Arida, Oscar W. Cummings, Naga Chalasani, Kris V. Kowdley. Clinical significance of serum autoantibodies in patients with NAFLD: results from the nonalcoholic steatohepatitis clinical research network. Hepatology International 2012; 6(1): 379 doi: 10.1007/s12072-011-9277-8
|
| 8 |
Yusuf Yilmaz, Fatih Eren, Ramazan Kurt, Oya Yonal, Zulfikar Polat, Ebubekir Senates, Mohammad Bacha, Nese Imeryuz. Serum galectin-3 levels in patients with nonalcoholic fatty liver disease. Clinical Biochemistry 2011; 44(12): 955 doi: 10.1016/j.clinbiochem.2011.05.015
|
| 9 |
Chetan Mandelia, Elizabeth Collyer, Sana Mansoor, Rocio Lopez, Sara Lappe, Valerio Nobili, Naim Alkhouri. Plasma Cytokeratin‐18 Level As a Novel Biomarker for Liver Fibrosis in Children With Nonalcoholic Fatty Liver Disease. Journal of Pediatric Gastroenterology and Nutrition 2016; 63(2): 181 doi: 10.1097/MPG.0000000000001136
|
| 10 |
Pietro Vajro, Selvaggia Lenta, Piotr Socha, Anil Dhawan, Patrick McKiernan, Ulrich Baumann, Ozlem Durmaz, Florence Lacaille, Valerie McLin, Valerio Nobili. Diagnosis of Nonalcoholic Fatty Liver Disease in Children and Adolescents. Journal of Pediatric Gastroenterology and Nutrition 2012; 54(5): 700 doi: 10.1097/MPG.0b013e318252a13f
|
| 11 |
Floriane Rudwill, Audrey Bergouignan, Caroline Gastebois, Guillemette Gauquelin‐Koch, Etienne Lefai, Stéphane Blanc, Chantal Simon. Effect of enforced physical inactivity induced by 60‐day of bed rest on hepatic markers of NAFLD in healthy normal‐weight women. Liver International 2015; 35(6): 1700 doi: 10.1111/liv.12743
|
| 12 |
Yusuf Yilmaz, Oya Yonal, Ramazan Kurt, Yesim Ozen Alahdab, Fatih Eren, Osman Ozdogan, Cigdem Ataizi Celikel, Nese Imeryuz, Cem Kalayci, Erol Avsar. Serum levels of omentin, chemerin and adipsin in patients with biopsy-proven nonalcoholic fatty liver disease. Scandinavian Journal of Gastroenterology 2011; 46(1): 91 doi: 10.3109/00365521.2010.516452
|
| 13 |
Sandra Page, Aybike Birerdinc, Michael Estep, Maria Stepanova, Arian Afendy, Emanuel Petricoin, Zobair Younossi, Vikas Chandhoke, Ancha Baranova, Andrea Motta. Knowledge-Based Identification of Soluble Biomarkers: Hepatic Fibrosis in NAFLD as an Example. PLoS ONE 2013; 8(2): e56009 doi: 10.1371/journal.pone.0056009
|
| 14 |
Yusuf Yilmaz, Engin Ulukaya. Molecular signatures of nonalcoholic fatty liver disease: The present and future. Hepatology 2010; 51(5): 1866 doi: 10.1002/hep.23438
|
| 15 |
Abdelfattah M. Attallah, Mohamed El-Far, Camelia A. Abdel Malak, Mohamed M. Omran, Gamal E. Shiha, Khaled Farid, Lamiaa A. Barakat, Mohamed S. Albannan, Ahmed A. Attallah, Mohamed A. Abdelrazek, Mohamed S. Elbendary, Refaat Sabry, Gehan A. Hamoda, Mohamed M. Elshemy, Abdallah A. Ragab, Basma M. Foda, Sanaa O. Abdallah. HCC-DETECT: a combination of nuclear, cytoplasmic, and oncofetal proteins as biomarkers for hepatocellular carcinoma. Tumor Biology 2015; 36(10): 7667 doi: 10.1007/s13277-015-3501-4
|
| 16 |
Yusuf Yilmaz. Serum proteomics for biomarker discovery in nonalcoholic fatty liver disease. Clinica Chimica Acta 2012; 413(15-16): 1190 doi: 10.1016/j.cca.2012.04.019
|
| 17 |
Kenneth Cusi, Zhi Chang, Steve Harrison, Romina Lomonaco, Fernando Bril, Beverly Orsak, Carolina Ortiz-Lopez, Joan Hecht, Ariel E. Feldstein, Amy Webb, Christopher Louden, Martin Goros, Fermin Tio. Limited value of plasma cytokeratin-18 as a biomarker for NASH and fibrosis in patients with non-alcoholic fatty liver disease. Journal of Hepatology 2014; 60(1): 167 doi: 10.1016/j.jhep.2013.07.042
|
| 18 |
Pierluigi Marzuillo, Anna Grandone, Laura Perrone, Emanuele Miraglia del Giudice. Controversy in the diagnosis of pediatric non-alcoholic fatty liver disease. World Journal of Gastroenterology 2015; 21(21): 6444-6450 doi: 10.3748/wjg.v21.i21.6444
|
| 19 |
Yusuf Yilmaz, Ramazan Kurt, Cem Kalayci. Apoptosis in nonalcoholic steatohepatitis with normal aminotransferase values: zooming in on cytokeratin 18 fragments. Biomarkers in Medicine 2010; 4(5): 743 doi: 10.2217/bmm.10.65
|
| 20 |
Kameliya Bratoeva, Silviya Nikolova, Albena Merdzhanova, George St. Stoyanov, Eleonora Dimitrova, Javor Kashlov, Nikolay Conev, Mariya Radanova. Association Between Serum CK-18 Levels and the Degree of Liver Damage in Fructose-Induced Metabolic Syndrome. Metabolic Syndrome and Related Disorders 2018; 16(7): 350 doi: 10.1089/met.2017.0162
|
| 21 |
Yusuf Yilmaz. Cytokeratins in hepatitis. Clinica Chimica Acta 2011; 412(23-24): 2031 doi: 10.1016/j.cca.2011.09.002
|
| 22 |
Yusuf Yilmaz, Oya Yonal, Ramazan Kurt, Arzu Y. Oral, Fatih Eren, Osman Ozdogan, Ferda Ari, Cigdem A. Celikel, Seniz Korkmaz, Engin Ulukaya, Nese Imeryuz, Cem Kalayci, Erol Avsar. Serum levels of osteoprotegerin in the spectrum of nonalcoholic fatty liver disease. Scandinavian Journal of Clinical and Laboratory Investigation 2010; 70(8): 541 doi: 10.3109/00365513.2010.524933
|
| 23 |
Onpan Cheung, Arun J Sanyal. Recent advances in nonalcoholic fatty liver disease. Current Opinion in Gastroenterology 2010; 26(3): 202 doi: 10.1097/MOG.0b013e328337b0c4
|
| 24 |
Y. Yilmaz. Review article: is non‐alcoholic fatty liver disease a spectrum, or are steatosis and non‐alcoholic steatohepatitis distinct conditions?. Alimentary Pharmacology & Therapeutics 2012; 36(9): 815 doi: 10.1111/apt.12046
|
| 25 |
Kareem A. Attallah, Mohamed S. Albannan, Khaled Farid, Sherine M. Rizk, Nevine Fathy. HCC-Check: A Novel Diagnostic Tool for Early Detection of Hepatocellular Carcinoma Based on Cytokeratin-1 and Epithelial Membrane Antigen: A Cross-Sectional Study. Technology in Cancer Research & Treatment 2024; 23 doi: 10.1177/15330338241234790
|
| 26 |
Michael Kruse, Margrit Kemper, Sofiya Gancheva, Martin Osterhoff, Dirk Dannenberger, Daniel Markgraf, Jürgen Machann, Johannes Hierholzer, Michael Roden, Andreas F. H. Pfeiffer. Dietary Rapeseed Oil Supplementation Reduces Hepatic Steatosis in Obese Men—A Randomized Controlled Trial. Molecular Nutrition & Food Research 2020; 64(21) doi: 10.1002/mnfr.202000419
|
| 27 |
Raika Jamali, Abbas Arj, Mohsen Razavizade, Mohammad Hossein Aarabi. Prediction of Nonalcoholic Fatty Liver Disease Via a Novel Panel of Serum Adipokines. Medicine 2016; 95(5): e2630 doi: 10.1097/MD.0000000000002630
|
| 28 |
Yida Zhang, Susan S. Baker, Robert D. Baker, Ruixin Zhu, Lixin Zhu, Anna Alisi. Systematic Analysis of the Gene Expression in the Livers of Nonalcoholic Steatohepatitis: Implications on Potential Biomarkers and Molecular Pathological Mechanism. PLoS ONE 2012; 7(12): e51131 doi: 10.1371/journal.pone.0051131
|
| 29 |
Agnes Molnar, Johannes Haybaeck, Carolin Lackner, Pavel Strnad. The cytoskeleton in nonalcoholic steatohepatitis: 100 years old but still youthful. Expert Review of Gastroenterology & Hepatology 2011; 5(2): 167 doi: 10.1586/egh.11.5
|